SLA 0.00% $3.34 silk laser australia limited

Agree Sav-J, very little to be taken seriously here….which is...

  1. 52 Posts.
    Agree Sav-J, very little to be taken seriously here….which is likely what the RMOH said when they saw Solascam’s clinical trial data for Ropren – more holes than Swiss cheese. Only people worth LOLing about are the Board of Directors of Solascam for not updating the market as to why June 30 has passed without Ropren approval after Denis Kilroy all-but-promised this would occur.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.